{"id":"310f5dd8-b00f-535e-94c7-5ecf2b8654a7","stable_key":"ea2f0904-ab2c-5d1e-a3d4-3f7ecdd70cd6:caf-withdraw-beta","predicate":"changes","statement":"Acute withdrawal decreased EEG beta-2 power.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"d9283f08-ee2d-560f-a3db-fd68b1bda005","mechanism_event_label":"Stopping after repeated use produced a measurable response.","subject":{"id":"819b234b-c649-5a6c-852b-eb1fe634f6fb","slug":"caffeine-withdrawal-state","display_name":"Acute withdrawal after repeated caffeine exposure","entity_type_key":"cellular_process"},"object":{"id":"d34e1b25-b590-50d0-92d2-0b3e5f436f19","slug":"eeg-beta2-power","display_name":"EEG beta-2 power","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"d9283f08-ee2d-560f-a3db-fd68b1bda005","stable_key":"ea2f0904-ab2c-5d1e-a3d4-3f7ecdd70cd6:caf-withdraw-beta-event","event_type":"observed_relationship","label":"Stopping after repeated use produced a measurable response.","description":"Acute withdrawal decreased EEG beta-2 power.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"819b234b-c649-5a6c-852b-eb1fe634f6fb","slug":"caffeine-withdrawal-state","display_name":"Acute withdrawal after repeated caffeine exposure","entity_type_key":"cellular_process"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"d34e1b25-b590-50d0-92d2-0b3e5f436f19","slug":"eeg-beta2-power","display_name":"EEG beta-2 power","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"ef028472-7c33-583d-b52e-40676004d370","slug":"caffeine","display_name":"Caffeine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"16 regular users; double-blind within-subject study; at least 14 days on 400 mg/day or placebo, with acute challenges.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Withdrawal is adaptation to repeated exposure, not an essential-nutrient deficiency. Blood-flow velocity is not absolute cerebral perfusion.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Caffeine collection; salts, coffee, species and coexposure contexts retain their identities.","comparator":null,"unit":null,"notes":"","entity":{"slug":"caffeine","display_name":"Caffeine","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"Stopping after repeated use produced a measurable response.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects. · 2009 · https://pubmed.ncbi.nlm.nih.gov/19241060/ · DOI 10.1007/s00213-009-1489-4","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"9a82cae8-e0ab-53b2-8d41-209593c14476","evidence_kind":"source_excerpt","locator":"Lines 124-130","start_line":124,"end_line":130,"excerpt":"## caf-withdraw-beta\nStopping after repeated use produced a measurable response.\nAcute withdrawal decreased EEG beta-2 power.\nModel: 16 regular users; double-blind within-subject study; at least 14 days on 400 mg/day or placebo, with acute challenges.\nLimitations: Withdrawal is adaptation to repeated exposure, not an essential-nutrient deficiency. Blood-flow velocity is not absolute cerebral perfusion.\nEvidence access: Primary abstract\nCaffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects. · 2009 · https://pubmed.ncbi.nlm.nih.gov/19241060/ · DOI 10.1007/s00213-009-1489-4","model_system":"16 regular users; double-blind within-subject study; at least 14 days on 400 mg/day or placebo, with acute challenges.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access stated with the claim.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"40a654db-878c-5471-bc6c-88f4f52599c0","stable_key":"import-ea2f0904-ab2c-5d1e-a3d4-3f7ecdd70cd6","title":"Caffeine: receptors, metabolism, nutrient interactions, adaptation and discovery questions (2026-09-18)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"780d73d4abd45a0284d2cc0c646dbe8432ae347362891a4b98a19a61341a7325","revision_id":"f36ffb0a-d6df-522f-b783-5e30214b9e26","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}